erythrodysesthesia syndrome

e·ryth·ro·dys·es·the·si·a syn·drome

tingling sensation of the palms and soles, progressing to severe pain and tenderness with erythema and edema; caused by continuous infusion therapy.
Farlex Partner Medical Dictionary © Farlex 2012
References in periodicals archive ?
Chemotherapy-associated palmar-plantar erythrodysesthesia syndrome. Ann Intern Med.
Due to grade 3 palmar-plantar erythrodysesthesia syndrome occurring 12 months after dosing, the dose was reduced to 1000 mg.
20 April 2011 - Spanish biopharmaceutical company Advancell has announced the initiation of a clinical Phase IIb study of its treatment ATH008 for palmar-plantar erythrodysesthesia syndrome, or hand-foot syndrome, a painful side effect of chemotherapy.

Full browser ?